Bezlotoxumab
Zinplava (bezlotoxumab) is an antibody pharmaceutical. Bezlotoxumab was first approved as Zinplava on 2016-10-21. It is used to treat clostridium infections in the USA. It has been approved in Europe to treat pseudomembranous enterocolitis.
Trade Name | Zinplava |
---|---|
Common Name | Bezlotoxumab |
Indication | clostridium infections, pseudomembranous enterocolitis |
Drug Class | Monoclonal antibodies |
